[ Price : $8.95]
FDA approves a Pfizer NDA for Talzenna (talazoparib) with Astellas Xtandi (enzalutamide) for treating certain patients with gene-m...[ Price : $8.95]
The Harvard Drug Group recalls a single lot of dronabinol capsules (2.5 mg) and ziprasidone hydrochloride capsules (20 mg) after r...[ Price : $8.95]
FDA extends by three months its review of a GSK NDA for momelotinib, indicated for treating myelofibrosis patients with anemia.[ Price : $8.95]
Philips issues an urgent field safety notice about its Azurion and Allura Xper systems installed with the FlexMove option, which c...[ Price : $8.95]
A just-posted, four-item Form FDA-483 sheds light on medical device reporting and other violations cited in a 2022 inspection of i...[ Price : $8.95]
Eli Lilly says a head-to-head clinical trial comparing its migraine drug Emgality (galcanezumab-gnlm) to Pfizers Nurtec ODT (Rimeg...[ Price : $8.95]
FDA approves Premia Spines TOPS System as an alternative to spinal fusion for treating certain patients with degenerative spondylo...[ Price : $8.95]
FDA publishes a CVM guidance entitled #171 Demonstrating Bioequivalence for Soluble Powder Oral Dosage Form Products and Type A Me...